Meitheal Pharmaceuticals has Regadenoson Injection Now Available

Share Facebook icon Twitter icon Linkedin icon
March 20, 2023

Meitheal Pharmaceuticals (Meitheal) is pleased to announce that we have launched Regadenoson Injection, 0.4 mg/5 mL pre-filled syringe.

Meitheal will offer Regadenoson Injection in a carton of 1 syringe.

ABOUT REGADENOSON INJECTION

Regadenoson Injection is a pharmacologic stress agent indicated for radionuclide myocardial perfusion imaging (MPI) in patients unable to undergo adequate exercise stress. For full prescribing information, please click on the following link.

 

Learn more about Regadenoson Injection Now Available

New Launches
Meitheal Pharmaceuticals has Mitomycin for Injection, USP Now Available

Meitheal Pharmaceuticals has Mitomycin for Injection, USP Now Available

 Meitheal Pharmaceuticals has Pemetrexed for Injection, USP 750 mg and 1 g Now Available

Meitheal Pharmaceuticals has Pemetrexed for Injection, USP 750 mg and 1 g Now Available
This Website Uses Cookies

This website uses cookies to help give you the best experience when you visit. By clicking “Accept Cookies,” you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and help us make improvements to our site. You can read more about our use of cookies in our Privacy Policy.

Manage Consent Preferences

Always Active

Necessary cookies enable core functionality such as security and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

These cookies are set to provide quantitative measures of website visitors. Information collected with these cookies is used in operations to measure website performance. With the usage of these cookies we are able to count visits and traffic sources to improve our site. The data is collected in a way that does not directly identify anyone.
Accept all cookies Confirm my choices